Seno Medical Instruments has received more than $3 million to launch commercial operations to further develop its patented laser optoacoustic breast imaging technology.
The technology fuses light and ultrasound to create strong contrast between normal and cancerous tissues to detect cancer in its earliest stages without breast compression or exposure to x-ray, according to the San Antonio-based company. Potential clinical applications include the diagnosis of ovarian, prostate, colorectal, bladder, and melanoma cancers, as well as cardiovascular uses, the company said.
By AuntMinnie.com staff writers
July 20, 2006
Copyright © 2006 AuntMinnie.com
